The Chip Seller Became The Lender At 5.3%

Reuters (exclusive, Oct 1), citing Anthropic's IPO prospectus: Broadcom has agreed to lend Anthropic up to $42bn to finance infrastructure spending. The notes can convert into Anthropic shares, and the facility could cover about a third of a $125.2bn five-year TPU lease commitment. The prospectus flags Broadcom's dual role as supplier and lender as creating "potential conflicts of interest," and warns that certain payment or performance defaults could make much of the lease obligations immediately due while restricting use of the facility. Anthropic is expected to be Broadcom's largest compute customer in 2027; Broadcom projects about $115bn of AI semiconductor revenue in FY27 and $230bn in FY28. Wells Fargo (via headline relay, Oct 1): AWS will raise reserved GPU prices 15% on Oct 7 after a 20% increase in July — the fourth consecutive quarterly increase — with H100/H200 and B200/B300 pricing up 40-75% year to date. US 10-year yield touched 5.33% on Oct 1, highest since 2002. The 10-year rose 85bp in Q3, its largest quarterly increase since 2016 (WSJ / Dow Jones Market Data).

Layer 3 — the cost side of the scissors is moving fast. Rental compute up 40-75% this year and Micron printing an 87% gross margin on Sep 30 say the value is being captured upstream by the suppliers. The lab carries a cost base rising double digits per quarter against 2025 revenue of $4.6bn and $518bn of forward obligations, roughly 80% non-cancelable. The output side of the scissors — what the model sells for — is the half still to be measured. Layer 4 — Broadcom now sits in four places in one counterparty: chip supplier, equipment lessor, lender, and potential shareholder through conversion. That is the vendor-financing structure the framework flags. Part of the most-watched AI revenue guide in semiconductors is funded by the vendor's own balance sheet. The acceleration clause is the crack: the event that makes the lease obligations due is the same event that restricts the facility meant to cover them, so the backstop disappears exactly when it is needed. Oracle's Jupiter force majeure is the same shape at a different counterparty — and that paper already trades below 90. Vein 10 — what the seller doesn't finance, public equity has to, and the IPO arrives with the risk-free rate at a 23-year high. Warsh named AI capex competing for capital as a driver of yields; the long end is also breaking globally on fiscal and energy, with the UK 30-year above 6% for the first time since 1998. For the lab, the cause doesn't matter. Every dollar of funding has to clear a higher hurdle while compute costs compound. Demand is real. It is not self-funding, and the cost of funding it just went up.